Market Place
Sourcing Support
PharmTech Interviews Dr. Hayes On Peptide OSD Drug Challenges
12 Nov 2024 //
PRESS RELEASE
CordenPharma Expands Supply Across Six Technology Platforms
11 Nov 2024 //
PRESS RELEASE
CordenPharma TSAB Talks Drug Delivery & AI In CDMOs’ Future
29 Oct 2024 //
PRESS RELEASE
Oral Solid Dosage Forms: Science Inside! (Part 1
29 Oct 2024 //
PRESS RELEASE
CordenPharma Launches GMP Oral Solid Dose Clinical Manufacturing
29 Oct 2024 //
PRESS RELEASE
CPHI Milan: Dr. Houldsworth On CDMOs And Pharma’s Future
28 Oct 2024 //
PRESS RELEASE
CPHI Video: Experts Discuss Lipids, mRNA, LNPs, And Injectables
28 Oct 2024 //
PRESS RELEASE
CordenPharma’s €900M GLP-1 Expansion Unveiled At CPHI Milan
15 Oct 2024 //
PRESS RELEASE
CPHI Milan: Drs. Hayes & Freifeld On API And Drug Trends
15 Oct 2024 //
PRESS RELEASE
CPHI Milan 2024: Dr. Houldsworth On Innovator Support Expansion
08 Oct 2024 //
PRESS RELEASE
Wacker and CordenPharma Well Prepared to Tackle New Pandemics
03 Oct 2024 //
PRESS RELEASE
CordenPharma GLP-1 Peptide Expansion Aired On Swiss SRF TV
26 Jul 2024 //
PRESS RELEASE
Sr. VP Ayoub On End-To-End Tides CDMO Growth Strategy
24 Jul 2024 //
PRESS RELEASE
CordenPharma Launches LNP GMP Supply From Clinical To Commercial
24 Jul 2024 //
PRESS RELEASE
Crystallization Key For Complex Lipids And API Manufacturing
24 Jul 2024 //
PRESS RELEASE
CordenPharma €900M Peptide Investment For Pandemic Preparedness
24 Jul 2024 //
PRESS RELEASE
CordenPharma invests $981M to boost GLP-1 manufacture capacity
17 Jul 2024 //
FIERCEPHARMA
CordenPharma Invests €900m in Peptide Platform Expansion in the USA & Europe
15 Jul 2024 //
PR NEWSWIRE
Wacker And CordenPharma Enter Pandemic Readiness
24 Jun 2024 //
CONTRACT PHARMA
WACKER & CordenPharma Enter Pandemic Readiness on 1 June 2024
19 Jun 2024 //
PRESS RELEASE
CordenPharma & Certest: A Powerful Partnership Patented LNP Formulation
08 Jun 2024 //
PRESS RELEASE
CordenPharma & GENEPEP Celebrate Strong Collab Leveraging Peptide Drug Substance
17 Apr 2024 //
PRESS RELEASE
CordenPharma, GENEPEP Celebrate R&D Alliance
17 Apr 2024 //
PRESS RELEASE
CordenPharma Caponago Inaugurates New Packaging Department
10 Apr 2024 //
PRESS RELEASE
Unlocking Genetic Potential: Corden`s LNP Starter Kits Safeguard High Payloads
10 Apr 2024 //
PRESS RELEASE
CordenPharma Expands Early Clinical Peptide MFG to Launch IND-Targ Peptide API
10 Apr 2024 //
PRESS RELEASE
An Era of Transformation,Strategic Investment & Accelerated Growth 2023 to 2024
10 Apr 2024 //
PRESS RELEASE
CordenPharma Expands to Launch IND-Targeted Peptide API
06 Mar 2024 //
PRESS RELEASE
CordenPharma Launches LNP Starter Kits to Mitigate Loss of High-value Payloads
28 Feb 2024 //
PRESS RELEASE
CordenPharma Colorado Signs Off-Site Net Metering with Pivot Energy
14 Feb 2024 //
PR NEWSWIRE
CordenPharma & pHLIP Announce Strategic Alliance to Develop pHLIP LNP TDP
04 Jan 2024 //
PRESS RELEASE
Lilly hires CordenPharma to make diabetes drug Mounjaro`s active ingredient
19 Oct 2023 //
REUTERS
CordenPharma Establishes World-Class Technology & Science Advisory Board
25 Jul 2023 //
PR NEWSWIRE
CordenPharma Announces Entry into Oligonucleotide API Manufacturing
02 May 2023 //
PRESS RELEASE
Wacker, Cordenpharma, Lmu & Hu Berlin Train Ai Machine-Learning Algorithm
30 Mar 2023 //
PRESS RELEASE
Cordenpharma Expands Into Gmp Lipid Nanoparticle Formulation In Caponago
01 Feb 2023 //
PRESS RELEASE
CordenPharma Signs Agreement for the Manufacturing of a Commercial Peptide
11 Jan 2023 //
CONTRACTPHARMA
CordenPharma Joins Science Based Targets Initiative
02 Dec 2022 //
CONTRACTPHARMA
Highly Potent CDMO Manufacturing Trends & Expansion
20 Oct 2022 //
PRESS RELEASE
CDMO CEO Strategy to Grow Stronger Through Flexibility, Creativity & Resilience
13 Sep 2022 //
PRESS RELEASE
Mini-Tablet Dose Form Considerations for Pediatric Patients
11 Aug 2022 //
PRESS RELEASE
CordenPharma Increases xRNA-based Capabilities with a Strategic Investment
01 Jun 2022 //
CORDENPHARMA
Two investors team up for CordenPharma buyout following mRNA vaccine success
04 May 2022 //
ENDPTS
Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG
02 May 2022 //
CORDENPHARMA
Wacker and CordenPharma Will Produce mRNA Vaccines for Germany When Needed
13 Apr 2022 //
CONTRACTPHARMA
CordenPharma Increases Lipid Manufacturing Capacity
05 Mar 2022 //
CONTRACTPHARMA
CordenPharma Acquires Three Manufacturing Facilities from Vifor Pharma
01 Feb 2022 //
PRNEWSWIRE
Vifor Pharma Drives Transformation with Divestment of Non-Core Finished Drug
17 Dec 2021 //
CORDENPHARMA
CordenPharma Expands Specialty Lipids Production in Chenôve
02 Dec 2021 //
CONTRACTPHARMA
Corden Pharma Chenôve is laureates of France Relance
01 Dec 2021 //
PHARMANETWORK
CordenPharma Invests €9.7M in New CTD Facility at Plankstadt CoE
30 Nov 2021 //
CONTRACTPHARMA
CordenPharma Announces New Capacity Expansions at its US and Germany Sites
13 May 2021 //
PHARMTECH
CordenPharma Colorado to Double Largest Peptide Purification Suite
13 May 2021 //
PRESS RELEASE
Revolo Biotherapeutics, CordenPharma Enter Master Service Agreement
20 Apr 2021 //
CONTRACTPHARMA
CordenPharma to Expand Lipid Purification Capacity at its Colorado Site
19 Apr 2021 //
PHARMTECH
CordenPharma Colorado Increases US Peptide Manufacturing Capacity
25 Nov 2020 //
CONTRACTPHARMA
CordenPharma Colorado Increases US Peptide Manufacturing Capacity through Innovation & Investment – First Phase
25 Nov 2020 //
PRESS RELEASE
CordenPharma Colorado Completes Highly Potent API Laboratory Expansion
20 Oct 2020 //
PRESS RELEASE
CordenPharma’s Weekly Update to COVID-19 (Novel Coronavirus)
18 Oct 2020 //
PRESS RELEASE
Filling in: How Stevanato Group Supports CordenPharma’s Expansion
07 Oct 2020 //
PRESS FRELEASE
